Ori Biotech
8 known investors
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Investors · 8
Amadeus Capital PartnersLondon · $50K – $12.7M
Kindred CapitalLondon
Novalis LifeSciencesPortsmouth
Delin VenturesreportedLondon · $216K – $2.2M
Northpond VenturesreportedBethesda · $100K – $5M
Octopus VenturesreportedLondon · $130K – $1.3M
Puhua Capitalreported · 2 sourcesHangzhou · $1.4M – $112M
Also in the syndicate · 1
Chimera Abu Dhabi
Funding
SEC filings, press & company announcements$100M disclosed across 1 round · 2022
- $100MSeries BJan 2022 · 5 sources
Novalis LifeSciences (lead), Amadeus Capital Partners, Chimera Abu Dhabi, Delin Ventures, Northpond Ventures, Octopus Ventures, Puhua Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ori Biotech do?
- Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
- Who are Ori Biotech's investors?
- Ori Biotech's investors include Amadeus Capital Partners, Kindred Capital, Novalis LifeSciences, Delin Ventures, Northpond Ventures, Octopus Ventures, Puhua Capital.
- How much funding has Ori Biotech raised?
- Ori Biotech has disclosed $100M raised across 1 round.